vs
Side-by-side financial comparison of GULF RESOURCES, INC. (GURE) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
GULF RESOURCES, INC. is the larger business by last-quarter revenue ($9.0M vs $6.5M, roughly 1.4× Prelude Therapeutics Inc). Prelude Therapeutics Inc runs the higher net margin — -303.5% vs -394.3%, a 90.9% gap on every dollar of revenue. On growth, GULF RESOURCES, INC. posted the faster year-over-year revenue change (303.4% vs 116.7%).
EOG Resources, Inc. is an American energy company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in the Heritage Plaza building in Houston, Texas.
GURE vs PRLD — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.0M | $6.5M |
| Net Profit | $-35.7M | $-19.7M |
| Gross Margin | — | — |
| Operating Margin | -3.7% | -314.1% |
| Net Margin | -394.3% | -303.5% |
| Revenue YoY | 303.4% | 116.7% |
| Net Profit YoY | -921.1% | 38.9% |
| EPS (diluted) | — | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $9.0M | $6.5M | ||
| Q2 25 | $8.3M | — | ||
| Q3 24 | — | $3.0M | ||
| Q4 23 | $6.9M | — | ||
| Q3 23 | $5.9M | — | ||
| Q2 23 | $8.0M | — | ||
| Q1 23 | $9.3M | — | ||
| Q4 22 | $18.6M | — |
| Q3 25 | $-35.7M | $-19.7M | ||
| Q2 25 | $-773.8K | — | ||
| Q3 24 | — | $-32.3M | ||
| Q4 23 | $-58.8M | — | ||
| Q3 23 | $-1.8M | — | ||
| Q2 23 | $-681.8K | — | ||
| Q1 23 | $-557.7K | — | ||
| Q4 22 | $-2.7M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | 8.5% | — | ||
| Q1 23 | 27.2% | — | ||
| Q4 22 | — | — |
| Q3 25 | -3.7% | -314.1% | ||
| Q2 25 | -9.0% | — | ||
| Q3 24 | — | -1145.9% | ||
| Q4 23 | -114.7% | — | ||
| Q3 23 | -39.1% | — | ||
| Q2 23 | -11.5% | — | ||
| Q1 23 | -8.6% | — | ||
| Q4 22 | -2.7% | — |
| Q3 25 | -394.3% | -303.5% | ||
| Q2 25 | -9.3% | — | ||
| Q3 24 | — | -1075.7% | ||
| Q4 23 | -855.6% | — | ||
| Q3 23 | -30.3% | — | ||
| Q2 23 | -8.5% | — | ||
| Q1 23 | -6.0% | — | ||
| Q4 22 | -14.5% | — |
| Q3 25 | — | $-0.26 | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $-0.43 | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $55.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $107.5M | $58.5M |
| Total Assets | $131.9M | $94.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $55.0M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $153.6M | ||
| Q4 23 | $72.2M | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
| Q3 25 | $107.5M | $58.5M | ||
| Q2 25 | $142.2M | — | ||
| Q3 24 | — | $156.4M | ||
| Q4 23 | $205.2M | — | ||
| Q3 23 | $260.7M | — | ||
| Q2 23 | $260.3M | — | ||
| Q1 23 | $274.8M | — | ||
| Q4 22 | $271.6M | — |
| Q3 25 | $131.9M | $94.8M | ||
| Q2 25 | $164.6M | — | ||
| Q3 24 | — | $197.2M | ||
| Q4 23 | $226.7M | — | ||
| Q3 23 | $278.9M | — | ||
| Q2 23 | $278.3M | — | ||
| Q1 23 | $295.7M | — | ||
| Q4 22 | $292.4M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.7M | $-19.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $6.7M | $-19.1M | ||
| Q2 25 | $-559.3K | — | ||
| Q3 24 | — | $-27.3M | ||
| Q4 23 | $-42.6M | — | ||
| Q3 23 | $-1.1M | — | ||
| Q2 23 | $6.2M | — | ||
| Q1 23 | $4.8M | — | ||
| Q4 22 | $14.0M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $-27.4M | ||
| Q4 23 | — | — | ||
| Q3 23 | $-16.3M | — | ||
| Q2 23 | $6.2M | — | ||
| Q1 23 | $4.8M | — | ||
| Q4 22 | $9.7M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | -912.0% | ||
| Q4 23 | — | — | ||
| Q3 23 | -277.7% | — | ||
| Q2 23 | 77.0% | — | ||
| Q1 23 | 51.6% | — | ||
| Q4 22 | 52.2% | — |
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | 2.1% | ||
| Q4 23 | — | — | ||
| Q3 23 | 258.3% | — | ||
| Q2 23 | 0.2% | — | ||
| Q1 23 | 0.4% | — | ||
| Q4 22 | 23.4% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GURE
| Bromine | $8.1M | 89% |
| Shandong Shouguang Shenrunfa Marine Chemical Company Limited | $1.4M | 15% |
PRLD
Segment breakdown not available.
